Skip to main content
×
Home
    • Aa
    • Aa

Is Continuous Subglottic Suctioning Cost-Effective for the Prevention of Ventilator-Associated Pneumonia?

  • Corinne Hallais (a1), Véronique Merle (a1), Pierre-Gildas Guitard (a2), Anne Moreau (a1), Valérie Josset (a1), Denis Thillard (a1), Suzanne Haghighat (a3), Benoit Veber (a2) and Pierre Czernichow (a1)...
Abstract
Objective.

To establish whether continuous subglottic suctioning (CSS) could be cost-effective.

Design.

Cost-benefit analysis, based on a hypothetical replacement of conventional ventilation (CV) with CSS.

Setting.

A surgical intensive care unit (SICU) of a tertiary care university hospital in France.

Patients.

All consecutive patients receiving ventilation in the SICU in 2006.

Methods.

Efficacy data for CSS were obtained from the literature and applied to the SICU of our hospital. Costs for CV and CSS were provided by the hospital pharmacy; costs for ventilator-associated pneumonia (VAP) were obtained from the literature. The cost per averted VAP episode was calculated, and a sensitivity analysis was performed on VAP incidence and on the number of tubes required for each patient.

Results.

At our SICU in 2006, 416 patients received mechanical ventilation for 3,487 ventilation-days, and 32 VAP episodes were observed (7.9 episodes per 100 ventilated patients; incidence density, 9.2 episodes per 10,000 ventilation-days). Based on the hypothesis of a 29% reduction in the risk of VAP with CSS than CV, 9 VAP episodes could have been averted. The additional cost of CSS for 2006 was estimated to be €10,585.34. The cost per averted VAP episode was €1,176.15. Assuming a VAP cost of €4,387, a total of 3 averted VAP episodes would neutralize the additional cost. For a low VAP incidence of 6.6%, the cost per averted VAP would be €1,323. If each patient required 2 tubes during ventilation, the cost would be €1,383.69 per averted VAP episode.

Conclusion.

Replacement of CV with CSS was cost-effective even when assuming the most pessimistic scenario of VAP incidence and costs.

Copyright
Corresponding author
Department of Epidemiology and Public Health, Rouen University Hospital, 1 rue de Germont, 76031 Rouen Cedex, France (veronique.merle@chu-rouen.fr)
References
Hide All
1. ChastreJ. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867903.
2. IbrahimEH, TracyL, ChérieH, FraserVJ, KollefMH. The occurrence of ventilator-associated pneumonia in a community hospital. Chest 2001;120:555561.
3. FagonJY, ChastreJ, HanceAJ, MontraversP, NovaraA, GibertC. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281288.
4. HeylandDK, CookDJ, GriffithL, KeenanSP, Brun-BuissonC; Canadian Critical Trials Group. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999;159:12491256.
5. DrakulovicMB, TorresA, BauerTT, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomized trial. Lancet 1999;354:18511858.
6. CookD, GuyattG, MarshallJ, et al; Canadian Critical Care Trials Group. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. NEngl J Med 1998;338:791797.
7. KressJP, VinayakAG, LevittJ, SchweickertWD, et al. Daily sedative interruption in mechanically ventilated patients at risk for coronary artery disease. Crit Care Med 2007;35:365371.
8. BabcockHM, ZackJE, GarrisonT, et al. An educational intervention to reduce ventilator-associated pneumonia in an integrated health system. Chest 2004;125:22242231.
9. OmraneR, EidJ, PerreaultMM, et al. Impact of a protocol for prevention of ventilator-associated pneumonia. Ann Pharma-cother 2007;41:13901396.
10. TablanOC, AndersonLJ, BesserR, BridgesC, HajjehR. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53(RR-3):136.
11. DezfulianC, ShojaniaK, CollardHR, KimHM, MatthayMA, SaintS. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med 2005;118:14501451.
12. MahulP, AuboyerC, JospeR, et al. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intensive Care Med 1992;18:2025.
13. VallèsJ, ArtigasA, RelioJ, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995;122:179186.
14. KollefMH, SkubasNJ, SundtTM. A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest 1999;116:13391346.
15. BoH, HeL, QuJ. Influence of the subglottic secretion drainage on the morbidity of ventilator associated pneumonia in mechanically ventilated patients. Zhonghua Jie He He Hu Xi Za Zhi 2000;23:472474.
16. SmuldersK, van der HoevenH, Weers-PothoffI, Vanden-broucke-GraulsC. A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Chest 2002;121:679681.
17. MerleV, HalláisC, TavolacciMP, et al. Validity of medical staff assessment at admission of patient's risk of nosocomial infection: a prospective study in a surgical intensive care unit. Intensive Care Med 2006;32:915918.
18. ShorrAF, O'MalleyPG. Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia: potential economic implications. Chest 2001;119:228235.
19. YoungquistP, CarrollM, FarberM, etal. Implementing a ventilator bundle in a community hospital, it Comm J Qual Patient Saf 2007;33:219225.
20. ResarR, PronovostP, HaradenC, SimmondsT, RaineyT, NolanT. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf 2005;31:243248.
21. RAISIN. Surveillance des infections nosocomiales en réanimation, France, résultats 2004. REA-RAISIN and Institut de Veille Sanitaire, September 2005. http://www.invs.sante.fr/publications/2005/rea_raisin_2004/rea_raisin_2004.pdf. Accessed March 8, 2010.
22. KappsteinI, SchulgenG, BeyerU, GeigerK, SchumacherM, DaschnerFD. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis 1992;11:504508.
23. PapazianL, BregeonF, ThirionX. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996;154:9197.
24. SafdarN, DezfulianC, CollardHR, SaintS. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33:21842190.
25. CocanourCS, Ostrosky-ZeichnerL, PeningerM, et al. Cost of a ventilator-associated pneumonia in a shock trauma intensive care unit. Surg Infect (Larchmt) 2005;6:6572.
26. HarveyRC, MillerP, LeeJA, BowtonDL, MacGregorDA. Potential mucosal injury related to continuous aspiration of subglottic secretion device. Anesthesiology 2007;107:666669.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 18 *
Loading metrics...

Abstract views

Total abstract views: 265 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd October 2017. This data will be updated every 24 hours.